Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus
Annals of the Rheumatic Diseases · 2025-08 · 84 (8) · 1342-1353
DOI: 10.1016/j.ard.2025.04.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2025-08. Verfasst von Dionysis Nikolopoulos und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, and Center for Molecular Medicine (CMM…. Hauptthemen laut MEDLINE: Lupus Vasculitis, Central Nervous System, Complement System Proteins, B-Lymphocytes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Swedish Rheumatism Association, Ulla and Gustaf af Ugglas Foundation.
Abstract (Originalsprache)
OBJECTIVES: The management of neuropsychiatric systemic lupus erythematosus (NPSLE) remains challenging because of clinical heterogeneity and the complexity of pathophysiologic mechanisms involved. We sought to determine the molecular signature of NPSLE and its endotypes towards novel biomarkers and targeted therapies. METHODS: Whole-blood RNA sequencing from 308 patients with systemic lupus erythematosus (119 with NPSLE, 189 non-NPSLE) and 72-matched healthy controls (HCs) were performed. Supervised pathway enrichment analysis and unsupervised weighted gene coexpression network analysis were applied to distinguish clinically and molecularly defined NPSLE endotypes. RESULTS: Compared with HCs, patients with NPSLE demonstrated dysregulation of adaptive immune responses along with upregulation of interleukin (IL)-1, IL-6, IL-17, and IL-12/IL-23 signalling pathways. The comparison between NPSLE and non-NPSLE groups revealed a robust upregulation of complement cascade, DNA damage response, adaptive immunity, and IL-1 and IL-6 signalling. Furthermore, active NPSLE exhibited a strong autophagy signature. The B cell and complement cascade signatures exhibited a gradual upregulation across the non-NPSLE, inactive NPSLE, and active NPSLE subgroups. Within NPSLE, diffuse syndromes correlated positively with the oxidative phosphorylation module, while antiphospholipid antibody-positive NPSLE was not associated with specific signatures by unsupervised analysis. NPSLE endotypes such as cognitive dysfunction, seizures, psychosis, and optic neuritis were associated with distinct transcriptomic signatures namely IL-6 signalling and leukocyte migration, DNA damage response, inflammation, and type-I interferon, respectively. CONCLUSIONS: The clinical heterogeneity of NPSLE appears to be associated with molecular diversity, with certain endotypes or syndromes exhibiting distinct gene signatures. Upregulation of adaptive immune response and complement cascade suggests that complement inhibitors and B cell-targeted therapies could be further explored in NPSLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, and Center for Molecular Medicine (CMM), Stockholm, Sweden; Laboratory of Autoimmunity and Inflammation, Cen…
- Laboratory of Autoimmunity and Inflammation, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece.
- Laboratory of Autoimmunity and Inflammation, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece; Department of Internal Medicine 3-Rheum…
- 4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
- Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, and Center for Molecular Medicine (CMM), Stockholm, Sweden; Science for Life Laboratory, Department of Oncol…
- Rheumatology, Clinical Immunology and Allergy Department, Medical School University of Crete, Heraklion, Greece.
Förderung
- European Commission
- Swedish Rheumatism Association
- Ulla and Gustaf af Ugglas Foundation
- European Research Council
- Karolinska Institutet
- Foundation King Gustaf V 80-årsfond
- Åke Wiberg Stiftelse
Zitieren
APA
Nikolopoulos, D., Sentis, G., Kitsios, I., Garantziotis, P., Kapsala, N., Pieta, A., Flouda, S., Manolakou, T., Nikoloudaki, M., Banos, A., Chavatza, K., Parodis, I., Filia, A., Bertsias, G., Fanouriakis, A., & Boumpas, D. T. (2025). Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus. Annals of the Rheumatic Diseases, 84(8), 1342-1353. https://doi.org/10.1016/j.ard.2025.04.006
Vancouver
Nikolopoulos D, Sentis G, Kitsios I, Garantziotis P, Kapsala N, Pieta A, et al. Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus. Annals of the Rheumatic Diseases. 2025;84(8):1342-1353. doi:10.1016/j.ard.2025.04.006
BibTeX
@article{Nikolopoulos2025,
author = {Nikolopoulos, Dionysis and Sentis, George and Kitsios, Iasonas and Garantziotis, Panagiotis and Kapsala, Noemin and Pieta, Antigone and Flouda, Sofia and Manolakou, Theodora and Nikoloudaki, Myrto and Banos, Aggelos and Chavatza, Katerina and Parodis, Ioannis and Filia, Anastasia and Bertsias, George and Fanouriakis, Antonis and Boumpas, Dimitrios T},
title = {Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus},
journal = {Annals of the Rheumatic Diseases},
year = {2025},
volume = {84},
number = {8},
pages = {1342--1353},
doi = {10.1016/j.ard.2025.04.006}
}
EUVIMED